Literature DB >> 22952318

Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice.

Juyong Brian Kim1, Andres Deluna, Imran N Mungrue, Christine Vu, Delila Pouldar, Mete Civelek, Luz Orozco, Judy Wu, Xuping Wang, Sarada Charugundla, Lawrence W Castellani, Marta Rusek, Hieronim Jakubowski, Hieronim Jakobowski, Aldons J Lusis.   

Abstract

BACKGROUND: The human 9p21.3 chromosome locus has been shown to be an independent risk factor for atherosclerosis in multiple large-scale genome-wide association studies, but the underlying mechanism remains unknown. We set out to investigate the potential role of the 9p21.3 locus neighboring genes, including Mtap, the 2 isoforms of Cdkn2a, p16Ink4a and p19Arf, and Cdkn2b, in atherosclerosis using knockout mice models. METHODS AND
RESULTS: Gene-targeted mice for neighboring genes, including Mtap, Cdkn2a, p19Arf, and Cdkn2b, were each bred to mice carrying the human APO*E3 Leiden transgene that sensitizes the mice for atherosclerotic lesions through elevated plasma cholesterol. We found that the mice heterozygous for Mtap developed larger lesions compared with wild-type mice (49623±21650 versus 18899±9604 μm(2) per section [mean±SD]; P=0.01), with morphology similar to that of wild-type mice. The Mtap heterozygous mice demonstrated changes in metabolic and methylation profiles and CD4(+) cell counts. The Cdkn2a knockout mice had smaller lesions compared with wild-type and heterozygous mice, and there were no significant differences in lesion size in p19Arf and Cdkn2b mutants compared with wild type. We observed extensive, tissue-specific compensatory regulation of the Cdkn2a and Cdkn2b genes among the various knockout mice, making the effects on atherosclerosis difficult to interpret.
CONCLUSIONS: Mtap plays a protective role against atherosclerosis, whereas Cdkn2a appears to be modestly proatherogenic. However, no relation was found between the 9p21 genotype and the transcription of 9p21 neighboring genes in primary human aortic vascular cells in vitro. There is extensive compensatory regulation in the highly conserved 9p21 orthologous region in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22952318      PMCID: PMC3608429          DOI: 10.1161/CIRCULATIONAHA.111.064881

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  46 in total

1.  GeneNote: whole genome expression profiles in normal human tissues.

Authors:  Orit Shmueli; Shirley Horn-Saban; Vered Chalifa-Caspi; Michael Shmoish; Ron Ophir; Hila Benjamin-Rodrig; Marilyn Safran; Eytan Domany; Doron Lancet
Journal:  C R Biol       Date:  2003 Oct-Nov       Impact factor: 1.583

2.  Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation.

Authors:  Atsuhiro Kanayama; Jun-Ichiro Inoue; Yoshioko Sugita-Konishi; Makoto Shimizu; Yusei Miyamoto
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

3.  Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells.

Authors:  Jinfeng Miao; Jinqiu Zhang; Liuhai Zheng; Xiaoming Yu; Wei Zhu; Sixiang Zou
Journal:  Amino Acids       Date:  2011-08-02       Impact factor: 3.520

4.  Prevention of atherosclerotic lesion development in mice by taurine.

Authors:  S Murakami; Y Kondo; K Tomisawa; T Nagate
Journal:  Drugs Exp Clin Res       Date:  1999

5.  Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.

Authors:  E Latres; M Malumbres; R Sotillo; J Martín; S Ortega; J Martín-Caballero; J M Flores; C Cordón-Cardo; M Barbacid
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

6.  The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis.

Authors:  A Díez-Juan; V Andrés
Journal:  FASEB J       Date:  2001-09       Impact factor: 5.191

7.  CD4 cell lymphopenia and atherosclerosis in renal transplant recipients.

Authors:  Didier Ducloux; Bruno Challier; Philippe Saas; Pierre Tiberghien; Jean-Marc Chalopin
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

8.  Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

Authors:  J X Zhou; G A Niehans; A Shar; J B Rubins; S P Frizelle; R A Kratzke
Journal:  Lung Cancer       Date:  2001-04       Impact factor: 5.705

9.  Antiatherogenic effect of taurine in high fat diet fed rats.

Authors:  S Sethupathy; C Elanchezhiyan; K Vasudevan; G Rajagopal
Journal:  Indian J Exp Biol       Date:  2002-10       Impact factor: 0.818

10.  Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects.

Authors:  Ursula Schwab; Anneli Törrönen; Leena Toppinen; Georg Alfthan; Markku Saarinen; Antti Aro; Matti Uusitupa
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

View more
  23 in total

Review 1.  Over 1000 genetic loci influencing blood pressure with multiple systems and tissues implicated.

Authors:  Claudia P Cabrera; Fu Liang Ng; Hannah L Nicholls; Ajay Gupta; Michael R Barnes; Patricia B Munroe; Mark J Caulfield
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

2.  Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.

Authors:  Ilakya Selvarajan; Anu Toropainen; Kristina M Garske; Maykel López Rodríguez; Arthur Ko; Zong Miao; Dorota Kaminska; Kadri Õunap; Tiit Örd; Aarthi Ravindran; Oscar H Liu; Pierre R Moreau; Ashik Jawahar Deen; Ville Männistö; Calvin Pan; Anna-Liisa Levonen; Aldons J Lusis; Sami Heikkinen; Casey E Romanoski; Jussi Pihlajamäki; Päivi Pajukanta; Minna U Kaikkonen
Journal:  Am J Hum Genet       Date:  2021-02-23       Impact factor: 11.025

Review 3.  The role of genetic risk factors in coronary artery disease.

Authors:  Sonny Dandona; Robert Roberts
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

Review 4.  Genetics and Genomics of Coronary Artery Disease.

Authors:  Milos Pjanic; Clint L Miller; Robert Wirka; Juyong B Kim; Daniel M DiRenzo; Thomas Quertermous
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

5.  Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.

Authors:  Nicholas J Leeper; Azad Raiesdana; Yoko Kojima; Ramendra K Kundu; Henry Cheng; Lars Maegdefessel; Ryuji Toh; G-One Ahn; Ziad A Ali; D Ryan Anderson; Clint L Miller; Scott C Roberts; Joshua M Spin; Patricia E de Almeida; Joseph C Wu; Baohui Xu; Karen Cheng; Maximilian Quertermous; Soumajit Kundu; Kim E Kortekaas; Erica Berzin; Kelly P Downing; Ronald L Dalman; Philip S Tsao; Eric E Schadt; Gary K Owens; Thomas Quertermous
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

Review 6.  Mechanical influences on cardiovascular differentiation and disease modeling.

Authors:  Evan L Teng; Adam J Engler
Journal:  Exp Cell Res       Date:  2019-02-19       Impact factor: 3.905

7.  Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.

Authors:  Wei Wang; Seon Oh; Mark Koester; Sandra Abramowicz; Nan Wang; Alan R Tall; Carrie L Welch
Journal:  Circ Cardiovasc Genet       Date:  2016-04-20

Review 8.  Nutrigenetics and nutrigenomics of atherosclerosis.

Authors:  Aksam J Merched; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

Review 9.  Functional genomics of the 9p21.3 locus for atherosclerosis: clarity or confusion?

Authors:  Hsiao-Huei Chen; Naif A M Almontashiri; Darlène Antoine; Alexandre F R Stewart
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

10.  Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

Authors:  Yoko Kojima; Kelly Downing; Ramendra Kundu; Clint Miller; Frederick Dewey; Hope Lancero; Uwe Raaz; Ljubica Perisic; Ulf Hedin; Eric Schadt; Lars Maegdefessel; Tom Quertermous; Nicholas J Leeper
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.